Nearly half (46%) of women with OP had compensatory secondary hyperparathyroidism, but a significant adverse BMD effect in ascending PTH tertials, could not be demonstrated (p = 0.720). The gene discussed is PTH; the disease is secondary hyperparathyroidism.